NGAL is considered a promising biomarker for early diagnosis of AKI (Arena et al., 2010; Han et al., 2012), and its expression level is correlated with the severity of renal impairment during the acute and chronic inflammatory state. The gene discussed is LCN2; the disease is acute kidney injury.